Skip to main content

Table 1 Characteristics and outcomes in patients with infective endocarditis and patients with hepatitis B virus with and without antineutrophil cytoplasmic antibodies among all previously reported cohort studies

From: Antineutrophil cytoplasmic antibodies (ANCA)-positive patient with infective endocarditis and chronic hepatitis B virus: a case report and review of the literature

 

Patients with IE (n = 274)

Patients with HBV (n = 223)

P value

Mean age (yr)a

58.55

49.1

 

Males/femalesa

135/64

132/91

0.07

ANCA-positive/ANCA-negative

73/201

42/181

0.04

ANCA (by IIF)

 c-ANCA

56

18

0.08

 p-ANCA

14

21

0.01

 c-ANCA + p-ANCA

─

1

0.79

ANCA (by ELISA)b

 PR3

34

19

0.9

 MPO

7

8

0.21

 PR3 + MPO

4

─

0.33

Outcomes

 Death c

37 (ANCA-positive 10)

4

<  0.001

  1. Abbreviations: ANCA Antineutrophil cytoplasmic antibodies, c-ANCA Cytoplasmic antineutrophil cytoplasmic antibodies, ELISA Enzyme-linked immunosorbent assay, HBV Hepatitis B virus, IE Infective endocarditis, IIF Indirect immunofluorescence, MPO Myeloperoxidase, p-ANCA Perinuclear antineutrophil cytoplasmic antibodies, PR3 Proteinase 3
  2. aOnly three references have mentioned age and sex in patients with IE among all five references
  3. bPR3- and MPO-ANCAs were detected by ELISA in patients with HBV only in two references
  4. cOnly four references describing patients with IE and two references describing patients with HBV have mentioned outcomes
Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947